Little Green Pharma (ASX:LGP) ROE % Adjusted to Book Value: -3.17% (As of Mar. 2026)


What is Little Green Pharma ROE % Adjusted to Book Value?

Little Green Pharma ASX:LGP ROE % Adjusted to Book Value is -3.17% as of Mar. 2026. The stock has 3 warning signs investors should review.

Little Green Pharma's ROE % for the quarter that ended in Mar. 2026 was -1.14%. Little Green Pharma's PB Ratio for the quarter that ended in Mar. 2026 was 0.36. Little Green Pharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -3.17%.

Little Green Pharma ROE % Adjusted to Book Value Related Terms

Little Green Pharma ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Little Green Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Little Green Pharma ROE % Adjusted to Book Value Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 21.26 -16.08 -18.93 9.11 -4.67

Little Green Pharma Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.02 -24.95 38.24 -4.62 -3.17

ASX:LGP vs ZTS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Little Green Pharma ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's ROE % Adjusted to Book Value falls into.


Little Green Pharma ROE % Adjusted to Book Value Calculation

Little Green Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-1.68% / 0.36
=-4.67%

Little Green Pharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-1.14% / 0.36
=-3.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -3.17% mean?
Little Green Pharma (ASX:LGP) has a ROE % Adjusted to Book Value of -3.17% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Little Green Pharma and its competitors.
Is Little Green Pharma's ROE % Adjusted to Book Value too high?
Little Green Pharma's current ROE % Adjusted to Book Value is -3.17%.
How does Little Green Pharma's ROE % Adjusted to Book Value compare to ZTS?
Little Green Pharma's ROE % Adjusted to Book Value of -3.17% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Little Green Pharma and its competitors. Little Green Pharma's current ROE % Adjusted to Book Value is -3.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.06 — trading 62.4% below its estimated fair value. The current ROE % Adjusted to Book Value is -3.17%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current ROE % Adjusted to Book Value is -3.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Little Green Pharma Business Description

Address 13A Bedbrook Place, Shenton Park, West Perth, Perth, WA, AUS, 6008
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).